| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 5FI5376A0X |
| InChI Key | SSRDSYXGYPJKRR-ZDUSSCGKSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C16H17ClN2OS |
| Molecular Weight | 320.85 |
| AlogP | 3.38 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 32.34 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 21.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Ion channel
Ligand-gated ion channel
5HT3 receptor
|
- | 299 | - | - | 51 | |
|
Ion channel
Ligand-gated ion channel
Nicotinic acetylcholine receptor
Nicotinic acetylcholine receptor alpha subunit
|
250-390 | - | - | 4-10 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Alzheimer Disease | 3 | D000544 | ClinicalTrials |
| Dementia | 3 | D003704 | ClinicalTrials |
| Schizophrenia | 2 | D012559 | ClinicalTrials |
| Liver Diseases | 1 | D008107 | ClinicalTrials |
| Psychotic Disorders | 1 | D011618 | ClinicalTrials |
| Kidney Diseases | 1 | D007674 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2151572 |
| DrugBank | DB11726 |
| FDA SRS | 5FI5376A0X |
| Guide to Pharmacology | 6926 |
| PDB | I33 |
| PubChem | 46196517 |
| SureChEMBL | SCHEMBL744767 |
| ZINC | ZINC000095579362 |